Is osteopontin stable in plasma and serum?

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 2, 2013, Pages

  Qin, Qin ^a   Hu, Zhide ^b   Deng, Anmei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

in vitro stability; inflammatory diseases; osteoponitin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; D DIMER; OSTEOPONTIN; PROTHROMBIN; THROMBIN;

BLOOD CLOTTING; COMMUNITY ACQUIRED PNEUMONIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; LETTER; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; RHEUMATOID ARTHRITIS; ROOM TEMPERATURE; SERUM; STORAGE TEMPERATURE; THERMOSTABILITY;

BLOOD CHEMICAL ANALYSIS; HUMANS; OSTEOPONTIN; PLASMA; SERUM;

EID: 84875413932     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0731     Document Type: Letter

References (15)

1. Lanteri P, Lombardi G, Colombini A, Grasso D, Banfi G. Stability of osteopontin in plasma and serum. Clin Chem Lab Med 2012;50:1979-84.
2. Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 2011; 61:265-80.
3. Weber GF. The cancer biomarker osteopontin: combination with other markers. Cancer Genomics Proteomics 2011;8:263-88.
4. Wong CK, Lit LC, Tam LS, Li EK, Lam CW. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005;44:602-6.
5. Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, et al. High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol 2007;41:167-72.
6. Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Umeshita-Sasai M, et al. Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol 2002;29:2061-7.
7. Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, et al. Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma. Int J Biol Markers 2010;25:164-70.
8. Rubio-Jurado B, Iniguez-Franco P, Reyes PA, Robles G, Salazar-Paramo M, Zavala-Cerna G, et al. The clinical significance of coagulation and the inflammatory response in autoimmunity. Clin Rev Allergy Immunol 2012;42:172-80.
9. Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, et al. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 2008;31:175-9.
10. Agapakis DI, Tsantilas D, Psarris P, Massa EV, Kotsaftis P, Tziomalos K, et al. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology 2010;15:796-803.
11. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-61.
12. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teraoka H. Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin Chim Acta 2001;305:181-6.
13. Daves M, Cemin R. Type B natriuretic peptide stability in frozen plasma. Clin Chem Lab Med 2007;45:1257-8.
14. Pereira M, Azevedo A, Severo M, Barros H. Long-term stability of endogenous B-type natriuretic peptide after storage at -20 degrees C or -80 degrees C. Clin Chem Lab Med 2008;46:1171-4.
15. Cemin R, Daves M. Long-term stability of endogenous B-type natriuretic peptide during storage at -20 degrees C. Clin Biochem 2008;41:1115.